Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Regeneron Pharmaceuticals, Inc. company logo
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. (REGN)

Profile

Company profile for Regeneron Pharmaceuticals, Inc. (REGN)
MetricValue
Full NameRegeneron Pharmaceuticals, Inc.
TickerNASDAQ: REGN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
Indexes
Websiteregeneron.com
Employees15,182

Key Metrics

Regeneron Pharmaceuticals, Inc. Key Details
MetricDateValue
Price$796.55
Price, 1D Change-0.56%
Market Cap$84B
TTM Dividend Yield0.22%
PE Ratio19.07
Beta0.58
Revenue$14B
Revenue, 1Y Change+8.27%
EPS$38.34
EPS, 1Y Change+10.25%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Regeneron Pharmaceuticals, Inc. chart

Events

Regeneron Pharmaceuticals, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.88
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

REGN Estimates
MetricDateValue
EPS$38.34
EPS Estimate$43.18
EPS Est. Change+12.63%
Revenue$14.20B
Revenue Estimate$14.21B
Revenue Est. Change+0.07%
Current Price$796.55
Price Target-$800.00
Price Tgt. Change-+0.43%

🔒 Log In To Unlock Full Data

EPS

REGN EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$42.53$34.77-18.24%
$44.92$38.34-14.66%
$43.18N/A+12.63%
$38.78N/A+1.15%
REGN EPS reported versus estimate values chart

Revenue

REGN revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$12.93B$13.12B+1.41%
$14.16B$14.20B+0.29%
$14.21BN/A+0.07%
$15.15BN/A+6.67%
REGN revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

REGN Performance
MetricDateValue
Price, 1Y+8.58%
Price, 3Y+17.06%
Market Cap, 1Y+4.11%
Market Cap, 3Y+12.25%
Revenue, 1Y+8.27%
Revenue, 3Y-11.63%
EPS, 1Y+10.25%
EPS, 3Y-46.73%

🔒 Log In To Unlock Full Data

Technical Indicators

REGN Technical Indicators
MetricDateValue
Current Price$796.55
SMA 200$607.64
SMA 200 vs Price-23.72%
SMA 50$730.68
SMA 50 vs Price-8.27%
Beta0.58
ATR$19.59
14-Day RSI62.58
10-Day Volatility29.18%
1-Year Volatility41.62%

Dividends

REGN Dividends
MetricDateValue
Last Paid$0.88
UpcomingN/AN/A
Dividend Yield-
Total Dividend-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

REGN Income & Profitability
MetricDateValue
Revenue$14.20B
EPS$38.34
Gross Profit$11.75B
Gross Margin82.74%
Operating Profit$4.09B
Operating Margin29.39%
Net Income$4.41B
Net Margin31.07%
EBITDA$5.32B

🔒 Log In To Unlock Full Data

Financial Health

REGN Financial Health
MetricDateValue
Debt To Equity0.07
Current Ratio4.73
Quick Ratio3.95
-
F-Score5
Altman Z-Score8.34

Valuations

REGN Valuations
MetricDateValue
PE Ratio19.07
PS Ratio5.88
PB Ratio2.70
EV/EBITDA17.90
Enterprise ValueN/A-

Balance Sheet

REGN Balance Sheet
MetricDateValue
Book Value$29.35B
Cash & Equivalents$2.49B
Total Assets$37.85B
Current Assets$18.66B
Total Liabilities$8.50B
Current Liabilities$3.94B
Total Debt$2.94B
Short Term Debt$30.30M
Accounts Payable$789.50M

Expenses

REGN Expenses
MetricDateValue
Total Expenses$10.11B
Operating Expenses$8.14B
Cost Of Goods Sold$2.45B
SG&A$2.95B
D&A$482.90M
Interest Expense$0.00
Income Tax$367.30M

Cash Flow

REGN Cash Flow
MetricDateValue
CFO$4.42B
CFI-$2.47B
CFF-$2.20B
Capex$881.60M
Free Cash Flow$3.54B

Recent analyst updates

REGN Recent analyst updates
MetricDateValue
Morgan Stanley→
Wells Fargo→
Canaccord Genuity→
BMO Capital→
Morgan Stanley→
Scotiabank→
HSBC
Wells Fargo→
UBS→
Wells Fargo→

Analyst sentiment

Sentiment over the past month
REGN analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
REGN institutional ownership distribution chart

Screeners with REGN

Data Sources & References

  1. REGN Official Website www.regeneron.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm
  4. List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
  5. List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
  6. REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
  7. REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn

FAQ

  • What is the ticker symbol for Regeneron Pharmaceuticals, Inc.?

    The ticker symbol for Regeneron Pharmaceuticals, Inc. is NASDAQ:REGN

  • Does Regeneron Pharmaceuticals, Inc. pay dividends?

    Yes, Regeneron Pharmaceuticals, Inc. pays dividends. The last payment was $0.88, with an ex-dividend date on November 20, 2025

  • What sector is Regeneron Pharmaceuticals, Inc. in?

    Regeneron Pharmaceuticals, Inc. is in the Healthcare sector

  • What industry is Regeneron Pharmaceuticals, Inc. in?

    Regeneron Pharmaceuticals, Inc. is in the Biotechnology industry

  • What country is Regeneron Pharmaceuticals, Inc. based in?

    Regeneron Pharmaceuticals, Inc. is headquartered in United States

  • When did Regeneron Pharmaceuticals, Inc. go public?

    Regeneron Pharmaceuticals, Inc. initial public offering (IPO) was on April 2, 1991

  • Is Regeneron Pharmaceuticals, Inc. in the S&P 500?

    Yes, Regeneron Pharmaceuticals, Inc. is included in the S&P 500 index

  • Is Regeneron Pharmaceuticals, Inc. in the NASDAQ 100?

    Yes, Regeneron Pharmaceuticals, Inc. is included in the NASDAQ 100 index

  • Is Regeneron Pharmaceuticals, Inc. in the Dow Jones?

    No, Regeneron Pharmaceuticals, Inc. is not included in the Dow Jones index

  • When was Regeneron Pharmaceuticals, Inc. last earnings report?

    Regeneron Pharmaceuticals, Inc.'s most recent earnings report was on October 28, 2025

  • When does Regeneron Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Regeneron Pharmaceuticals, Inc. is January 30, 2026